Cargando…

Long-term Relugolix Combination Therapy for Symptomatic Uterine Leiomyomas

In the LIBERTY 1 and LIBERTY 2 placebo-controlled trials, once-daily relugolix combination therapy reduced menstrual blood loss volume and pain in women with heavy menstrual bleeding associated with uterine leiomyomas and was well tolerated, with preservation of bone mineral density (BMD) through 24...

Descripción completa

Detalles Bibliográficos
Autores principales:	Al-Hendy, Ayman, Lukes, Andrea S., Poindexter, Alfred N., Venturella, Roberta, Villarroel, Claudio, McKain, Laura, Li, Yulan, Wagman, Rachel B., Stewart, Elizabeth A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Contents
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9665945/ https://www.ncbi.nlm.nih.gov/pubmed/36357960 http://dx.doi.org/10.1097/AOG.0000000000004988

Ejemplares similares

A plain language summary of the long-term relugolix combination therapy study for uterine fibroids
por: Al-Hendy, Ayman, et al.
Publicado: (2023)

Health-Related Quality of Life With Ulipristal Acetate for Treatment of Uterine Leiomyomas: A Randomized Controlled Trial
por: Lukes, Andrea S., et al.
Publicado: (2019)

Elagolix Treatment for Up to 12 Months in Women With Heavy Menstrual Bleeding and Uterine Leiomyomas
por: Simon, James A., et al.
Publicado: (2020)

Depot Medroxyprogesterone Acetate Use and the Development and Progression of Uterine Leiomyoma
por: Harmon, Quaker E., et al.
Publicado: (2022)

A Randomized Open-Label Study of Relugolix Alone or Relugolix Combination Therapy in Premenopausal Women
por: Lukes, Andrea, et al.
Publicado: (2023)

Relugolix for oral treatment of uterine leiomyomas: a dose-finding, randomized, controlled trial
por: Hoshiai, Hiroshi, et al.
Publicado: (2021)

Relugolix/Estradiol/Norethisterone (Norethindrone) Acetate: A Review in Symptomatic Uterine Fibroids
por: Syed, Yahiya Y.
Publicado: (2022)

Uterine Fibroids: A Podcast on Patient and Physician Perspectives on Medical Management and a New Medical Therapy (Relugolix Combination Therapy)
por: Venable, Sateria R., et al.
Publicado: (2023)

Health Disparities in Uterine Cancer: Report From the Uterine Cancer Evidence Review Conference
por: Whetstone, Sara, et al.
Publicado: (2022)

Innovative Oral Treatments of Uterine Leiomyoma
por: Sabry, Mohamed, et al.
Publicado: (2012)

Correction: Relugolix/Estradiol/Norethisterone (Norethindrone) Acetate: A Review in Symptomatic Uterine Fibroids
por: Syed, Yahiya Y.
Publicado: (2022)

Executive Summary of the Uterine Cancer Evidence Review Conference
por: Chelmow, David, et al.
Publicado: (2022)

World Health Organization Recommendation for Using Uterine Balloon Tamponade to Treat Postpartum Hemorrhage
por: Weeks, Andrew D., et al.
Publicado: (2022)

A case of adenomyosis with leiomyoma that was effectively treated with relugolix and kamishoyosan add-on therapy
por: Sasamori, Yukifumi, et al.
Publicado: (2021)

Characteristics of submucosal leiomyomas that could cause severe hemorrhage with relugolix: an observational study
por: Wada, Yoshimitsu, et al.
Publicado: (2023)

Identification and potential role of telocytes in human uterine leiomyoma
por: Othman, Essam R., et al.
Publicado: (2016)

Herbal Medicinal Product Use During Pregnancy and the Postnatal Period: A Systematic Review
por: Muñoz Balbontín, Yolanda, et al.
Publicado: (2019)

Time Trends in Unilateral and Bilateral Oophorectomy in a Geographically Defined American Population
por: Erickson, Zachary, et al.
Publicado: (2022)

Long-Term Safety and Efficacy of Bremelanotide for Hypoactive Sexual Desire Disorder
por: Simon, James A., et al.
Publicado: (2019)

Efficacy and Long-term Outcomes of Repeated Large Loop Excision of the Transformation Zone of the Cervix
por: van de Sande, Anna J. M., et al.
Publicado: (2022)

Preterm Birth During the Coronavirus Disease 2019 (COVID-19) Pandemic in a Large Hospital System in the United States
por: Wood, Rachel, et al.
Publicado: (2021)

Cognitive Behavioral Therapy for Prenatal Insomnia: A Randomized Controlled Trial
por: Manber, Rachel, et al.
Publicado: (2019)

Identification, investigation and management of patient-to-patient hepatitis B transmission within an inpatient renal ward in North West England
por: Kliner, Merav, et al.
Publicado: (2015)

Selective progesterone receptor modulators for fertility preservation in women with symptomatic uterine fibroids(†)
por: Ali, Mohamed, et al.
Publicado: (2017)

Acute kidney injury risk assessment at the hospital front door: what is the best measure of risk?
por: Roberts, Gareth, et al.
Publicado: (2015)

Development of relugolix combination therapy as a medical treatment option for women with uterine fibroids or endometriosis
por: Arjona Ferreira, Juan C., et al.
Publicado: (2022)

Instructions to Authors
Publicado: (2009)

Supplement September 2008
Publicado: (2008)

Chapter 3: Use of ESAs and other agents to treat anemia in CKD
Publicado: (2012)

Chapter 5: Blood pressure management in kidney transplant recipients (CKD T)
Publicado: (2012)

Chapter 3: Assessment of lipid status in children with CKD
Publicado: (2013)

Section 1: Introduction and Methodology
Publicado: (2012)

Chapter 4: Red cell transfusion to treat anemia in CKD
Publicado: (2012)

Chapter 1: Diagnosis and evaluation of anemia in CKD
Publicado: (2012)

Chapter 1: Definition and classification of CKD
Publicado: (2013)

Section 5: Dialysis Interventions for Treatment of AKI
Publicado: (2012)

Chapter 7: Idiopathic membranous nephropathy
Publicado: (2012)

Chapter 2: General principles in the management of glomerular disease
Publicado: (2012)

Chapter 1: Assessment of lipid status in adults with CKD
Publicado: (2013)

Chapter 11: Henoch-Schönlein purpura nephritis
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_eb2a7ne6cf8mqddeecec9ik7g1